CO
Global Cord Blood Corporation
CORBF · OTC
$0.95 -0.11% (-$0.00)
1M -0.11%
Market Cap ¥908.9M
P/E Ratio 1.65x
Div. Yield -
ROE -
Piotroski F-Score Strong
8/9Valuation
100 /100
Cheap P/B 0.19x
P/E 1.65x
P/FCF 1.53x
Growth
58 /100
Stable FCF growth 7.95%
EPS growth 19.74%
Book val. growth 12.60%
Profitability
100 /100
Strong Op. margin 48.97%
Gross margin 85.26%
FCF margin 47.76%
Quality
34 /100
Average Asset turnover 0.15x
ROIC 6.26%
ROA 5.87%
Debt
100 /100
Low Net debt/EBITDA -10.14x
Debt/Equity 0.00x
Current ratio 10.73x
Stability
65 /100
Moderate EPS volatility 33.80%
Beta -0.77x
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CORBF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Ting Zheng
Employees
1,202
Headquarters
Hong Kong